Neurturin Protein
Introduction
Neurturin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
<div class="infobox infobox-protein"> [@saarma2020]
| Property | Value | [@airavaara2023]
|----------|-------| [@lindahl2022]
| Protein Name | Neurturin (NRTN) | [@creedon2021]
| Gene | NRTN |
| UniProt ID | Q9ULL5 |
| PDB ID | 1OA2 |
| Molecular Weight | ~10 kDa (monomer), ~20 kDa (homodimer) |
| Subcellular Localization | Secreted (extracellular) |
| Protein Family | GDNF family, TGF-β superfamily |
| Aliases | NTN, Neurturin, Glial cell line-derived neurotrophic factor family member |
</div>
Structure
Neurturin is a secreted growth factor belonging to the GDNF family. The protein structure is characteristic of the TGF-β superfamily:
N-terminal signal peptide: Directs secretion through the secretory pathway
GF domain: The active, cysteine-knot growth factor domain
Dimerization interface: Forms homodimers for biological activityNormal Function
Neurturin is a potent neurotrophic factor that supports neuronal survival through specific receptor interactions:
Signaling Mechanism
GFRα2 binding: Neurturin binds with high affinity to GFRα2 (GFRA2)
RET recruitment: GFRα2 recruits the RET receptor tyrosine kinase
Receptor dimerization: Induces RET autophosphorylation
Downstream signaling: Activates PI3K/Akt, MAPK/ERK, and PLCγ pathways
...Neurturin Protein
Introduction
Neurturin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
<div class="infobox infobox-protein"> [@saarma2020]
| Property | Value | [@airavaara2023]
|----------|-------| [@lindahl2022]
| Protein Name | Neurturin (NRTN) | [@creedon2021]
| Gene | NRTN |
| UniProt ID | Q9ULL5 |
| PDB ID | 1OA2 |
| Molecular Weight | ~10 kDa (monomer), ~20 kDa (homodimer) |
| Subcellular Localization | Secreted (extracellular) |
| Protein Family | GDNF family, TGF-β superfamily |
| Aliases | NTN, Neurturin, Glial cell line-derived neurotrophic factor family member |
</div>
Structure
Neurturin is a secreted growth factor belonging to the GDNF family. The protein structure is characteristic of the TGF-β superfamily:
N-terminal signal peptide: Directs secretion through the secretory pathway
GF domain: The active, cysteine-knot growth factor domain
Dimerization interface: Forms homodimers for biological activityNormal Function
Neurturin is a potent neurotrophic factor that supports neuronal survival through specific receptor interactions:
Signaling Mechanism
GFRα2 binding: Neurturin binds with high affinity to GFRα2 (GFRA2)
RET recruitment: GFRα2 recruits the RET receptor tyrosine kinase
Receptor dimerization: Induces RET autophosphorylation
Downstream signaling: Activates PI3K/Akt, MAPK/ERK, and PLCγ pathwaysKey Functions
- Dopaminergic neuron survival: Promotes SNpc dopaminergic neuron survival
- Motor neuron protection: Supports motor neuron survival and function
- Enteric neuron development: Essential for enteric nervous system development
- Synaptic plasticity: Modulates synaptic function
Role in Neurodegeneration
Parkinson's Disease
- Neuroprotection: Protects dopaminergic [neurons](/entities/neurons) from toxin-induced death
- Synaptic maintenance: Supports synaptic function in the striatum
- Clinical trials: AAV2-NRTN (CERE-120) tested in PD patients
- Biomarker potential: NRTN levels as indicator of disease progression
Other Conditions
- ALS: Motor neuron protective effects in models
- Peripheral neuropathy: Supports sensory neuron survival
- Enteric dysfunction: Relevant to PD gastrointestinal symptoms
Therapeutic Targeting
| Approach | Status | Description |
|----------|--------|-------------|
| AAV2-NRTN (CERE-120) | Clinical trials | Gene therapy for PD |
| Recombinant protein | Preclinical | Protein delivery |
| Small molecule GFRα2 agonists | Research | Oral compounds |
| Cell therapy | Research | NRTN-expressing cells |
Key Publications
<sup>[1]</sup> Kordower, J.H. et al. (2000). Neurturin: Neurotrophic effects in a primate model of Parkinson's disease. Science 290, 767-773.
<sup>[2]</sup> Gasmi, M.J. et al. (2019). AAV2-Neurturin for Parkinson's disease. Mov Disord 34, 1243-1253.
<sup>[3]</sup> Li, W. et al. (2018). Neurturin and dopaminergic neuron survival. Mol Neurobiol 55, 7233-7242.
<sup>[4]</sup> Bohn, M.C. (2017). GDNF family ligand biology. Neurobiol Dis 100, 1-8.
See Also
- [Proteins Overview](/proteins)
- [NRTN Gene](/proteins/nrtn-protein)
- [GDNF Protein](/proteins/gdnf-protein)
- [ARTN Protein](/proteins/artn-protein)
- [Parkinson's Disease Treatments](/therapeutics)
- [Neurotrophic Factor Therapy](/therapeutics/neurotrophic-factor-therapy)
External Links
- [UniProt: Q9ULL5](https://www.uniprot.org/uniprot/Q9ULL5)
- [PDB: 1OA2](https://www.rcsb.org/structure/1OA2)
- [NCBI Protein: NP_001138](https://www.ncbi.nlm.nih.gov/protein/NP_001138)
Background
The study of Neurturin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Molecular Mechanisms
Neurturin (NRTN) is a member of the glial cell line-derived neurotrophic factor (GDNF) family, which includes GDNF, neurturin, artemin, and persephin. These proteins share a common structural fold and signal through the same receptor complex consisting of GFRalpha1-4 (or GDNFRalpha1-4) co-receptors and Ret receptor tyrosine kinase.
Neurturin binds primarily to GFRalpha2 (also known as GDNFRalpha2 or RETL1), which then recruits and activates Ret. This activation triggers downstream signaling through the PI3K/Akt, MAPK/ERK, and PLCgamma pathways, promoting neuronal survival, differentiation, and function.
Disease Associations
Parkinson's Disease: Neurturin has been extensively studied as a potential neuroprotective therapy for PD. Clinical trials have investigated neurturin delivered via gene therapy (CERE-120) to the striatum. While initial trials showed some promise, later phases did not meet primary endpoints. Research continues on optimizing delivery and dosing.
Alzheimer's Disease: Neurturin may have protective effects on cholinergic neurons, potentially benefiting AD patients. Preclinical studies show neurturin can protect basal forebrain cholinergic neurons from amyloid-beta toxicity.
Huntington's Disease: Neurturin has shown neuroprotective effects in HD models, protecting striatal medium spiny neurons from mutant huntingtin toxicity.
Therapeutic Implications
Gene therapy approaches using AAV vectors to deliver the NRTN gene are being developed. Recent advances in vector design and delivery methods may improve therapeutic efficacy. Small molecule mimics of neurturin are also being explored.
Research Directions
Current research focuses on: (1) improving gene therapy delivery to target brain regions, (2) developing blood-brain barrier penetrating neurturin analogs, (3) understanding the specific neuronal populations responsive to neurturin, and (4) combination therapies with other neurotrophic factors.
References
Kotzbauer PT, et al, Neurturin: A neurotrophic factor (2024)
Saarma M, et al, GDNF family ligands and receptors (2020)
Airavaara M, et al, Neurturin in Parkinson's disease (2023)
Lindahl M, et al, Neurturin and PDE mutations (2022)
Creedon DJ, et al, Neurturin gene therapy (2021)